You may have heard that if breast cancer comes back, it’s most likely to happen within the first five to 10 years after you finish treatment. It’s natural to worry about your breast cancer recurring after treatment. If you’re like other MyBCTeam members, you’ll want more information.
One MyBCTeam member shared, “I’m constantly wondering if the cancer will recur.” Another member commented, “I try not to worry about recurrence, but the thoughts pop up in my mind.”
If you’ve been diagnosed with HER2-positive breast cancer, a fast-growing and aggressive type, you might worry more about it coming back. This is because HER2-positive breast cancer has a higher risk of recurrence compared to other types of breast cancer. HER2-positive breast cancer is also associated with early recurrence within five years of being diagnosed.
Breast cancer recurrence is when breast cancer comes back after you complete treatment.
Continue reading to learn more about HER2-positive breast cancer recurrence.
Your health care provider will likely test your breast cancer cells for HER2 when you have a biopsy or when your tumor is removed during surgery. A breast biopsy is a medical procedure where a small sample of breast tissue is taken using a special needle or during surgery. A pathologist then examines this sample to check for signs of breast cancer or other health conditions.
You can learn more about testing for HER2 here.
If your breast cancer cells have higher-than-normal levels of the HER2 protein, it’s known as HER2-positive breast cancer. Your cancer may be considered HER2-negative even if you have some HER2 protein in your cells. Talk to your cancer care team about your HER2 results.
The HER2 protein is a receptor that helps regulate how your healthy breast cells grow and divide. However, about 10 percent to 20 percent of people with breast cancer have a change in the HER2 gene that causes breast cancer cells to make more HER2 protein. When breast cancer cells have an excess of HER2 protein, they grow and divide abnormally or without proper control.
It’s important to know your HER2 status because it can affect the type of treatment you receive. Your HER2 status also influences your risk of cancer spreading (metastasis) and recurrence.
Breast cancer recurrence is when breast cancer comes back after you complete treatment. You may have a recurrence if your first treatment didn’t kill all of the cancer cells in your breast. The cancer cells that remain after breast cancer treatment may be dormant (inactive) for several years before they become activated to begin growing and spreading again. HER2-positive breast cancer has a recurrence peak of around 20 months.
There are three types of breast cancer recurrence:
After targeted therapy, about 25 percent of people with HER2-positive breast cancer experience a recurrence within 10 years.
If you develop cancer in the breast that hasn’t been previously treated for breast cancer, it’s not considered a recurrence. Instead, this is a new cancer or secondary cancer.
Your symptoms depend on the type of breast cancer recurrence. If you have a local recurrence, you may notice:
If you have a regional recurrence, you may notice:
The symptoms of a distant recurrence depend on what area of your body the cancer has spread to and may include the following symptoms:
If you experience symptoms of breast cancer recurrence, talk to your cancer care team right away. Breast cancer recurrence is diagnosed with many of the same tests you had during your original diagnosis, such as imaging tests, blood tests, and biopsy.
Some people with breast cancer have a higher risk of breast cancer recurrence, including people diagnosed with:
Studies have also looked at the risk of recurrence, specifically for people with early-stage HER2-positive breast cancer. Researchers found that the highest risk of HER2-positive breast cancer recurrence was in people with the following characteristics:
“I try not to worry about recurrence, but the thoughts pop up in my mind.”
— A MyBCTeam member
Talk to your oncology care team about your risk factors for the recurrence of HER2-positive breast cancer.
HER2-positive breast cancer is associated with early recurrence within five years of being diagnosed. A 2023 study found that for people with HER-2 positive breast cancer recurrence, most of them developed the recurrence in less than five years of their original diagnosis.
Your hormone receptor (HR) status also influences the time to recurrence. The previously mentioned study found that 75 percent of recurrences occurred within 3.05 years for people with HER2-positive, HR-positive breast cancer. In people with HER2-positive, HR-negative breast cancer, 75 percent of recurrences occurred within 2.79 years of the original diagnosis.
Your treatment options for breast cancer recurrence depend on the type of recurrence and your breast cancer subtype.
Local and regional recurrence may be treated with surgery. If you have a local recurrence, treatment may include a mastectomy (if you originally had breast-conserving surgery) or removal of the tumor. The affected lymph nodes may be surgically removed if you have a regional recurrence. Surgery may also be helpful in some cases of distant recurrence. Radiation therapy may be given before or after surgery for any type of recurrence, as well.
Systemic therapies are drug treatments that affect your whole body. HER2-positive breast cancer treatment is often treated with drugs that specifically target HER2, including:
HER2-positive targeted therapy may be combined with other treatment regimens, such as chemotherapy, hormone therapy, and immunotherapy. Talk to your cancer care team about the best treatment option for you.
Researchers don’t know why breast cancer comes back in some people and not in others. Breast cancer treatments can help reduce your risk of recurrence. The prediction of recurrence in this type of cancer is still under study, but the future is promising.
Before targeted therapies for HER2-positive breast cancer, the risk of recurrence within 10 years after treatment was between 30 percent and 50 percent. With targeted therapy, about 25 percent of people with HER2-positive breast cancer experience a recurrence within 10 years.
Other treatments, such as chemotherapy and hormone therapy, can also help reduce your recurrence risk. Talk to your cancer care team about the best treatments to help you lower your risk of HER2-positive breast cancer recurrence.
It may not be possible to prevent breast cancer recurrence. However, regular follow-ups with your cancer care team and breast self-exams can help you discover a breast cancer recurrence before it spreads and when it is easier to treat.
MyBCTeam is the social network for people with breast cancer and their loved ones. On MyBCTeam, more than 69,000 members come together to ask questions, give advice, and share their stories with others who understand life with breast cancer.
Do you have HER2-positive breast cancer? Are you worried about recurrence? Share your experiences in the comments below, or start a conversation by posting on your Activities page.
Get updates directly to your inbox.
Can CEA Defect Cancer After Treatment?
Become a member to get even more:
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.